Purpose: Tregs modulate immune responses directed to allo-and xenoantigens and are a promising therapeutic tool in organ transplantation. Challenges include Treg isolation and expansion to clinically-relevant numbers while maintaining stability. Clinical feasibility could be improved by efficient Treg cryopreservation for future infusions or expansions. We previously showed that abundant CD25+ thymocytes can be isolated from discarded pediatric thymuses and expanded to highly suppressive and stable Tregs. Here we studied whether thymic Tregs (tTregs) can be cryopreserved and the potential of expanded tTregs to suppress allogeneic and xenogeneic immune responses. Methods: Thymocytes were obtained by mechanical dissociation of thymuses collected during pediatric cardiac surgery. CD25+ tTregs were isolated by magnetic-bead cell separation and directly expanded or stored in liquid nitrogen for > 3 months, thawed and expanded with anti-CD3, IL-2, rapamycin and artificial antigen-presenting cells. Treg characteristics were assessed by analyzing phenotype and suppressive capacity of proliferation of anti-CD3/28-stimulated T cells, T cells stimulated with irradiated allogeneic monocyte-derived dendritic cells, or peripheral blood mononuclear cells (PBMC) stimulated with irradiated neonatal porcine islets. Results: The expansion capacity of cryopreserved tTregs was comparable to that of fresh tTregs (range: 11-36-fold expansion). Both expanded fresh and cryopreserved tTregs maintained high FOXP3 expression, contained few IFN-gamma, IL-2 or IL-17-producing cells and potently suppressed proliferation of anti-CD3/28-stimulated T cells. Furthermore, expanded tTregs were strong suppressors of both allogeneic and xenogeneic immune responses: > 80% inhibition of proliferation of allogeneic-stimulated T cells and > 70% inhibition of proliferation of xenogeneic-stimulated PBMC was observed at a 1:2.5 Treg:responder cell ratio. Conclusion: Expansion capacity, phenotype and function of tTregs were not affected by cryopreservation. Expanded tTregs potently suppressed allogeneic and xenogeneic-stimulated responder cells. These results indicate that discarded human thymus is an excellent source of abundant Tregs for cellular therapy in both allo-and xenotransplantation.
Targeting Human Follicular T-B Cell Interactions to Prevent Antibody Mediated Allo-Immune Responses C.C. Baan , 1 B.S. Rakké, 1 G.N. de Graav, 1 K. de Leur, 1 F.J. Dor, 2 M. Franquesa. 1 1 Internal Medicine, Erasmus MC, Rotterdam, Netherlands; 2 Surgery, Erasmus MC, Rotterdam, Netherlands. Purpose: Antibody-mediated rejection (ABMR) has been increasingly recognized as an important cause of allograft dysfunction. We hypothesize that T-B cell interactions are crucial in ABMR. Germinal center CD4 + CXCR5 + PD1 + ICOS + Bcl6 + T follicular helper (Tfh)-cells activate B cells, and play a pivotal role in the generation of efficient antibody responses through costimulatory molecules and cytokines. Here, we investigated whether blockade of the CD28-CD80/86 co-stimulatory athway and the IL-21 signaling pathway hampers B cell differentiation into antibody producing plasmablasts. Methods: Facs sorted T and B cells from human donor-derived spleens were co-cultured in a mixed lymphocyte reaction (MLR), mimicking lymphoid organ germinal center reactions in the absence and presence of an IL-21 receptor antagonist (anti-IL21R) (5,10, 20 ng/ml), and belatacept targeting the CD28-CD80/86 (10 ug/ml). Proliferation and differentiation of T and B cell subsets were analyzed after 7 days using flow cytometry. Results: CD4 T cell proliferation was not inhibited by anti-IL21R, while belatacept had a significant effect (3.7 fold reduction, p = 0.01). Furthermore, only in the presence of belatacept, a reduced number of alloactivated Tfh cells novel gm porcine hearts and new medical treatments into NHP transplant. Hemoxygenase-1 and A20 decrease apoptotic and inflammatory reactions. Methods: A biventricular working cardiovascular system was designed to perfuse both wild-type (wt) and quintuple gm (hemoxygenase-1/A20 plus hCD46, hCD55, hCD59) porcine hearts ex vivo; all hearts were (i) explanted with Bretschneider solution for cardioplegia, (ii) subjected to a cold ischemia for 150 minutes, (iii) reperfused with heparinized, diluted freshly drawn human blood. A 15 minutes reperfusion was performed before functional testing in a biventricular working heart mode. Cardiac function was investigated and necropsy performed after 180 minutes of perfusion. Results: After 150 minutes of perfusion cardiac index (6.8 ±3.9 vs. 1.7 ±2.3 p= 0.04), stroke volume index (0.054 ±0.027 vs. 0.018 ±0.021; p= 0.01) and coronary perfusion index (3.7 ±1.5 vs.1.4 ±1.0; p= 0.02) improved compared to wt. Cardiac weights were obtained both before and after perfusion. Gm hearts developed less myocardial edema (28 ±21 vs. 62 ±42; p 0.03). Histology revealed less hemorrhage and structural damage in the gm hearts. Conclusion: The tested genetic modifications significantly reduced acute xenoreactions. If combined with GGTA1-KO and h-thrombomodulin expression they are a promising basis to be used in future preclinical studies with non-human primates.
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